SHARPIN is an endogenous inhibitor of β1-integrin activation

  • Juha K Rantala
  • Jeroen Pouwels
  • Teijo Pellinen
  • Stefan Veltel
  • Petra Laasola
  • Elina Mattila
  • Christopher S Potter
  • Ted Duffy
  • John P Sundberg
  • Olli Kallioniemi
  • Janet A Askari
  • Martin J Humphries
  • Maddy Parsons
  • Marko Salmi
  • Johanna Ivaska

Abstract

Regulated activation of integrins is critical for cell adhesion, motility and tissue homeostasis. Talin and kindlins activate β1-integrins, but the counteracting inhibiting mechanisms are poorly defined. We identified SHARPIN as an important inactivator of β1-integrins in an RNAi screen. SHARPIN inhibited β1-integrin functions in human cancer cells and primary leukocytes. Fibroblasts, leukocytes and keratinocytes from SHARPIN-deficient mice exhibited increased β1-integrin activity, which was fully rescued by re-expression of SHARPIN. We found that SHARPIN directly binds to a conserved cytoplasmic region of integrin α-subunits and inhibits recruitment of talin and kindlin to the integrin. Therefore, SHARPIN inhibits the critical switching of β1-integrins from inactive to active conformations.

Bibliografische Daten

OriginalspracheEnglisch
ISSN1465-7392
DOIs
StatusVeröffentlicht - 01.11.2011
Extern publiziertJa
PubMed 21947080